Pharmaceutical giant Pfizer Inc. said Wednesday that it plans to apply for emergency use authorization in the United States for a potential COVID-19 vaccine “within days,” as it has shown the vaccine to be effective in clinical study.The two-dose vaccine, jointly developed with German firm BioNTech SE, met “all of the study’s primary efficacy endpoints,” the companies said in their press release, noting that an analysis indicated the vaccine was 95 percent effective in preventing the disease caused by the novel coronavirus.Last week, the companies released an interim analysis from the phase-th…
- Biden Administration To Focus On Domestic Extremism Threat - January 26, 2021
- Rudy Giuliani sued by Dominion Voting Systems for $1.3 billion - January 25, 2021
- Biden Signs Executive Order Granting Federal Workers $15 Minimum Wage & Labor Protections - January 23, 2021
- Biden Removes Trump’s Red ‘Diet Coke Button’ From Oval Office Desk - January 22, 2021
- Trump impeachment heads to Senate Monday, triggering trial - January 22, 2021
- ‘It must be done’: Pelosi vows to move quickly on Trump impeachment trial over Capitol riots - January 21, 2021
- Biden signs raft of orders, including to rejoin Paris climate accord - January 20, 2021
- Trump Considering Launching His Own Political Party, The ‘Patriot Party’ - January 20, 2021
- Hollywood actor union threatens to expel Trump - January 19, 2021
- Trump Could Face Prison Time In Georgia - January 18, 2021
